Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro

Yoon Woo Koh, Manisha H. Shah, Kitty Agarwal, Samantha K. McCarty, Bon Seok Koo, Victoria J. Brendel, Chaojie Wang, Kyle Porter, David Jarjoura, Motoyasu Saji, Matthew D. Ringel

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science